The overall objective of this research is to characterize the process of differentiation of human monocytes-macrophages from the precursor cells in bone marrow and in the peripheral blood to the macrophage stage with particular emphasis on the variation of antigenic expression and on the development of specific functions. The experimental models used will include: (1) established lines of human hematopoietic cells and primary cultures of leukemia cells induced to differentiate in vitro by different chemical or biological inducers; and (2) in vitro growth and differentiation of normal precursor and stem cells from bone marrow and peripheral blood. The general aims are to determine whether an imbalance in the expression of surface markers during induced differentiation of these cells exists. One of the results of the first year of this project was the finding that immune interferon induces both the receptor for the Fc fragment of monomeric IgG and differentiation aIong the monocytic lineage in myeloid cells. The current studies are mostly focused to analyze these effects of immune interferon and to compare them with those of other chemical and naturally occurring inducers. Immune interferon is effective both on immature and differentiated cells of the myelomonocytic lineage. In immature myeloid cells, both normal and leukemic, immune interferon induces differentiation, with acquisition of monocytic markers and functions and loss of proliferative ability. On differentiated cells (granulocytes, monocytes, macrophages), immune interferon acts as an activation factor, inducing increased expression of HLA-DR and Fc receptor, enhanced phagocytosis, antibody-dependent celI-mediated cytotoxicity, lysosomal enzyme release, and increased oxidative metabolism. (MB)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA032898-07
Application #
3170776
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1982-08-01
Project End
1990-05-31
Budget Start
1988-06-01
Budget End
1989-05-31
Support Year
7
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Grazia Cappiello, M; Sutterwala, F S; Trinchieri, G et al. (2001) Suppression of Il-12 transcription in macrophages following Fc gamma receptor ligation. J Immunol 166:4498-506
Geng, Y; Berencsi, K; Gyulai, Z et al. (2000) Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection. Infect Immun 68:2245-53
Geng, Y; Shane, R B; Berencsi, K et al. (2000) Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. J Immunol 164:5522-9
Peritt, D; Sesok-Pizzini, D A; Schretzenmair, R et al. (1999) C1.7 antigen expression on CD8+ T cells is activation dependent: increased proportion of C1.7+CD8+ T cells in HIV-1-infected patients with progressing disease. J Immunol 162:7563-8
Trinchieri, G; Scott, P (1999) Interleukin-12: basic principles and clinical applications. Curr Top Microbiol Immunol 238:57-78
Fox, F E; Kubin, M; Cassin, M et al. (1999) Retinoids synergize with interleukin-2 to augment IFN-gamma and interleukin-12 production by human peripheral blood mononuclear cells. J Interferon Cytokine Res 19:407-15
Schwarz, A; Grabbe, S; Grosse-Heitmeyer, K et al. (1998) Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system. J Immunol 160:4262-70
Gri, G; Savio, D; Trinchieri, G et al. (1998) Synergistic regulation of the human interleukin-12 p40 promoter by NFkappaB and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages. J Biol Chem 273:6431-8
Trinchieri, G (1998) Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 70:83-243
Aste-Amezaga, M; Ma, X; Sartori, A et al. (1998) Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol 160:5936-44

Showing the most recent 10 out of 83 publications